Overexpression of p28GANK accelerates the metastasis of oesophageal squamous cell carcinoma

Tang,Shanhong; Qin,Jianping; Liu,Weihui; Zheng,Xiushan; Wu,Xiaoling; Xu,Hui; Qiao,Lijuan; Fan,Quanshui; Zeng,Weizheng; Jiang,Mingde

doi:10.3892/mmr.2015.3286

Overexpression of p28GANK accelerates the metastasis of oesophageal squamous cell carcinoma

Authors:
- Shanhong Tang
- Jianping Qin
- Weihui Liu
- Xiushan Zheng
- Xiaoling Wu
- Hui Xu
- Lijuan Qiao
- Quanshui Fan
- Weizheng Zeng
- Mingde Jiang
View Affiliations

Affiliations: Department of Digestion, General Hospital of Chengdu Military Command, Chengdu, Sichuan 610083, P.R. China, Department of General Surgery, General Hospital of Chengdu Military Command, Chengdu, Sichuan 610083, P.R. China, Department of Thoracic Surgery, General Hospital of Chengdu Military Command, Chengdu, Sichuan 610083, P.R. China, Prevention and Control Centre of Disease of Chengdu Military Command, Chengdu, Sichuan 610083, P.R. China
Published online on: January 30, 2015 https://doi.org/10.3892/mmr.2015.3286
Pages: 4291-4296

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to evaluate the effects of p28GANK expression on the metastasis of oesophageal squamous cell carcinoma (ESCC) tissues and to investigate its roles in the metastasis of highly invasive and non‑invasive ESCC cell lines. Quantitative polymerase chain reaction (qPCR) and immunohistochemical analyses were performed to assess p28GANK mRNA and protein expression in ESCC tissues and to analyse its significance in ESCC metastasis. qPCR and western blot analyses were used to detect p28GANK mRNA and protein expression in highly invasive and non‑invasive cell lines. Subsequently, lentivirus‑mediated p28GANK short interfering RNA (siRNA) was transfected into highly invasive ESCC cells, and Transwell assays were performed to analyse the effects of p28GANK knockdown on their migration and invasion. The mean expression levels of p28GANK mRNA in the ESCC tissues of patients with metastasis were signiﬁcantly higher than those in the ESCC specimens from patients without metastasis. p28GANK expression in ESCC tissues was correlated with T‑stage, lymph node metastasis and lymphatic invasion. The mRNA and protein expression levels of p28GANK were significantly higher in highly invasive cell lines compared with those of matched, non‑invasive cell lines. Lentivirus‑mediated siRNA knockdown of p28GANK markedly decreased p28GANK expression in EC109‑P and EC9706‑P cells and supressed the metastasis of ESCC cells in vitro. In conclusion, p28GANK expression was increased in metastatic ESCC tissues and cells, and p28GANK knockdown decreased the metastatic ability of ESCC cells. These results suggested that p28GANK may be a potential therapeutic marker for ESCC metastasis.

View Figures

View References

1	Yu C, Chen K, Zheng H, et al: Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis. 30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
2	Mohebbi M, Mahmoodi M, Wolfe R, et al: Geographical spread of gastrointestinal tract cancer incidence in the Caspian Sea region of Iran: spatial analysis of cancer registry data. BMC Cancer. 8:1372008. View Article : Google Scholar : PubMed/NCBI
3	Gong T, Xue Z, Tang S, et al: Nuclear expression of Twist promotes lymphatic metastasis in esophageal squamous cell carcinoma. Cancer Biol Ther. 13:606–613. 2012. View Article : Google Scholar : PubMed/NCBI
4	Tang S, Gao L, Bi Q, et al: SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell carcinoma. PLoS One. 8:e521842013. View Article : Google Scholar : PubMed/NCBI
5	Xu G, Tang S, Yang J, et al: BMP7 expression in esophageal squamous cell carcinoma and its potential role in modulating metastasis. Dig Dis Sci. 58:1871–1879. 2013. View Article : Google Scholar : PubMed/NCBI
6	Meng Y, He L, Guo X, et al: Gankyrin promotes the proliferation of human pancreatic cancer. Cancer Lett. 297:9–17. 2010. View Article : Google Scholar : PubMed/NCBI
7	Tang S, Yang G, Meng Y, et al: Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer. Cancer Biol Ther. 9:88–95. 2010. View Article : Google Scholar
8	Fu J, Chen Y, Cao J, et al: p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phos-phoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways. Hepatology. 53:181–192. 2011. View Article : Google Scholar : PubMed/NCBI
9	Zhen C, Chen L, Zhao Q, et al: Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity. Oncogene. 32:3452–3460. 2013. View Article : Google Scholar
10	Li J, Knobloch TJ, Kresty LA, et al: Gankyrin, a biomarker for epithelial carcinogenesis, is overexpressed in human oral cancer. Anticancer Res. 31:2683–2692. 2011.PubMed/NCBI
11	Yang Y, Zhang C, Li L, et al: Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma. World J Surg Oncol. 10:1692012. View Article : Google Scholar : PubMed/NCBI
12	Gao L, Xie H, Dong L, et al: Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells. Mol Med Rep. 9:1032–1036. 2014.
13	Wang G, Rong J, Zhou Z and Duo J: Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells. Mol Biol (Mosk). 44:1010–1017. 2010. View Article : Google Scholar
14	Ortiz CM, Ito T, Tanaka E, et al: Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance. Int J Cancer. 122:325–332. 2008. View Article : Google Scholar
15	Bi Q, Tang S, Xia L, et al: Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One. 7:e401692012. View Article : Google Scholar : PubMed/NCBI
16	Higashitsuji H, Higashitsuji H, Itoh K, et al: The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell. 8:75–87. 2005. View Article : Google Scholar : PubMed/NCBI
17	Lozano G and Zambetti GP: Gankyrin: an intriguing name for a novel regulator of p53 and RB. Cancer Cell. 8:3–4. 2005. View Article : Google Scholar : PubMed/NCBI
18	Qian YW, Chen Y, Yang W, et al: p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis. Gastroenterology. 142:1547–1558. 2012. View Article : Google Scholar : PubMed/NCBI
19	Chu YW, Yang PC, Yang SC, et al: Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol. 17:353–360. 1997. View Article : Google Scholar : PubMed/NCBI
20	Tie J, Pan Y, Zhao L, et al: MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
21	Bai ZF, Tai Y, Li W, et al: Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer. Cancer Res. 73:4548–4558. 2013. View Article : Google Scholar : PubMed/NCBI
22	Mine H, Sakurai T, Kashida H, et al: Association of gankyrin and stemness factor expression in human colorectal cancer. Dig Dis Sci. 58:2337–2344. 2013. View Article : Google Scholar : PubMed/NCBI
23	Zhen C, Chen L, Zhao Q, et al: Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity. Oncogene. 32:3452–3460. 2013. View Article : Google Scholar